Prostate cancer is cancer that occurs in the prostate. Prostate cancer is the most frequently diagnosed male cancer and the fifth leading cancer-related mortality rate in men around the world. In 2020, there were 1,414,249 newly diagnosed cases and 375,000 fatalities worldwide due to this illness. The majority of prostate tumors grow slowly, are low-grade, have a modest risk, and are not particularly aggressive.
Age - Men under the age of 40 are less likely to develop prostate cancer than older men, although the risk increases significantly after age 50. Men older than 65 are infected by prostate cancer in about 6 out of 10 cases
Race/ethnicity - A man's risk of having prostate cancer is more than doubled if his father or sibling has the condition
Gene changes - Inherited mutations in the BRCA1 or BRCA2 genes linked to an elevated risk of breast and ovarian cancer can also raise the risk of prostate cancer in men (especially mutations in BRCA2)
Prostate cancer risk is higher in men who have Lynch syndrome, also known as hereditary non-polyposis colorectal cancer (HNPCC), a disorder caused by inherited gene alterations
Screening for prostate cancer - Prostate screening tests include:
1. Prostatectomy – includes the removal of affected tissues and lymph nodes of the prostate gland. This can be done by 2 techniques:
2. Radiation therapy includes -
3. Freezing or heating prostate tissue -
4. Chemotherapy
5. Immunotherapy
6. Targeted drug therapy
Read more such content on @ Hidoc Dr | Medical Learning App for Doctors
1.
Hair Growth After Cancer; 'Global' Early-Onset CRC; Retifanlimab Boosts OS in NSCLC
2.
According to JAMA, even four minutes a day of exercise can lower the risk of cancer.
3.
improvements in the treatment of prostate cancer resistant to chemotherapy.
4.
Many Americans unaware of links between HPV and cancers, poll reveals
5.
After two years, a significant left nasal obstruction was finally diagnosed.
1.
Breaking Down the Benefits and Risks of Hematopoietic Stem Cell Transplantation
2.
Fibroma: Understanding the Causes, Symptoms, and Treatment Options
3.
Clinical Pharmacology of Tumor Microenvironment-Activated Prodrugs
4.
Skin-Sparing Mastectomy: Balancing Cancer Control with Cosmetic Results
5.
How is Digital Innovation Revolutionizing Gynecologic Oncology Treatment and Patient Engagement?
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation